Deficiency of GDF-11 Accelerates TAC-Induced Heart Failure by Impairing Cardiac Angiogenesis

Area of Science:

• Cardiovascular Biology
• Molecular Cardiology
• Regenerative Medicine

Background:

• The precise role of Growth Differentiation Factor (GDF)-11 in cardiac diseases remains unclear.
• Understanding GDF-11's function is crucial for developing novel therapeutic strategies for heart conditions.

Purpose of the Study:

• To elucidate the specific role of GDF-11 in myocardial development and its impact on cardiac function under stress.
• To investigate the molecular mechanisms by which GDF-11 influences cardiac angiogenesis and disease progression.

Main Methods:

• Utilized GDF-11 knockout mouse models to assess cardiac development and response to pressure overload.
• Employed cell culture experiments with cardiomyocytes (CMs) to study GDF-11's effect on vascular endothelial growth factor (VEGF) expression.
• Investigated the involvement of the Akt/mTOR signaling pathway in mediating GDF-11's angiogenic effects.

Main Results:

• GDF-11 is dispensable for normal myocardial development and physiological growth.
• Absence of GDF-11 exacerbates heart failure under pressure overload by impairing adaptive angiogenesis.
• GDF-11 upregulates VEGF expression in CMs through activation of the Akt/mTOR pathway, promoting angiogenesis.
• Endogenous GDF-11 acts locally within myocardial tissue for self-regulation, not through systemic pathways.

Conclusions:

• GDF-11 is not essential for basic heart development but plays a critical role in maintaining cardiac function during stress.
• GDF-11's pro-angiogenic activity, mediated by the Akt/mTOR/VEGF axis, is crucial for combating heart failure.
• The study highlights GDF-11's function as a local regulator of myocardial angiogenesis, offering potential therapeutic targets for heart disease.